We are live on
!
Find out more
CPCM
Clifton Park Capital Management Portfolio holdings
AUM
$881M
1-Year Est. Return
5.59%
This Fund
S&P 500
This Quarter
Est. Return
+7.03%
1 Year Est. Return
+5.59%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.64B
AUM Growth
-$42.7M
(-2.5%)
Cap. Flow
-$123M
Cap. Flow
% of AUM
-7.46%
Top 10 Holdings %
Top 10 Hldgs %
86.78%
Holding
25
New
1
Increased
1
Reduced
13
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
|
+$5.83M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$2.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pediatrix Medical
MD
|
+$33.7M |
| 2 |
Monro
MNRO
|
+$24.8M |
| 3 |
AIRM
Air Methods Corp
AIRM
|
+$19.5M |
| 4 |
World Kinect Corp
WKC
|
+$18.3M |
| 5 |
RB Global
RBA
|
+$9.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 31.17% |
| 2 | Healthcare | 26.84% |
| 3 | Energy | 18.86% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Technology | 5.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
World Kinect Corp
WKC
$2.06B
| $310M | 18.86% |
5,391,488
-351,443
| -6% | -$18.3M |
|
|
2
Pediatrix Medical
MD
$2.2B
| $280M | 17.02% |
3,856,841
-484,853
| -11% | -$33.7M |
|
3
Snap-on
SNA
$21.5B
| $216M | 13.13% |
1,466,950
| – | – |
|
|
4
RB Global
RBA
$21.5B
| $151M | 9.16% |
6,036,565
-373,435
| -6% | -$9.53M |
|
5
Dorman Products
DORM
$4.22B
| $125M | 7.63% |
2,519,800
-16,200
| -0.6% | -$763K |
|
|
HMSY
6
DELISTED
HMS Holdings Corp.
HMSY
| $91.6M | 5.58% |
5,930,000
| – | – |
|
|
AIRM
7
DELISTED
Air Methods Corp
AIRM
| $81.3M | 4.95% |
1,746,000
-426,900
| -20% | -$19.5M |
|
8
Healthcare Services Group
HCSG
$1.61B
| $64.3M | 3.91% |
2,000,000
| – | – |
|
|
CLVS
9
DELISTED
Clovis Oncology, Inc.
CLVS
| $61.4M | 3.74% |
826,919
+36,364
| +5% | +$2.57M |
|
|
IPCM
10
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
| $45.8M | 2.79% |
982,723
-147,177
| -13% | -$6.42M |
|
|
11
Monro
MNRO
$414M
| $37.4M | 2.28% |
575,000
-404,197
| -41% | -$24.8M |
|
12
MarketAxess Holdings
MKTX
$4.47B
| $24.4M | 1.48% |
293,830
-6,170
| -2% | -$488K |
|
13
FTI Consulting
FCN
$5.14B
| $23.5M | 1.43% |
627,850
-11,599
| -2% | -$438K |
|
|
VIVO
14
DELISTED
Meridian Bioscience Inc
VIVO
| $20M | 1.22% |
1,050,000
-234,100
| -18% | -$4.33M |
|
|
TNGO
15
DELISTED
Tangoe, Inc.
TNGO
| $17.6M | 1.07% |
1,278,900
| – | – |
|
16
Acacia Research
ACTG
$437M
| $15.8M | 0.96% |
1,475,000
| – | – |
|
17
Liquidity Services
LQDT
$1.2B
| $14.9M | 0.91% |
1,510,164
| – | – |
|
|
NXGN
18
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $14.8M | 0.9% |
928,937
-314,626
| -25% | -$5.2M |
|
|
INWK
19
DELISTED
InnerWorkings, Inc.
INWK
| $13.5M | 0.82% |
2,011,900
| – | – |
|
|
ESI
20
DELISTED
ITT EDUCATIONAL SERVICES INC
ESI
| $10.2M | 0.62% |
1,504,266
-102,100
| -6% | -$798K |
|
|
CYTO
21
DELISTED
Altamira Therapeutics Ltd
CYTO
| $8.88M | 0.54% |
21
| – | – |
|
22
Strategic Education
STRA
$1.98B
| $8.01M | 0.49% |
150,000
| – | – |
|
|
EVFM
23
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $6.75M | 0.41% |
+9,129
| New | +$5.83M |
|
|
TIVO
24
DELISTED
Tivo Inc
TIVO
| $1.37M | 0.08% |
75,000
-294,900
| -80% | -$6.6M |
|
|
ENSV
25
DELISTED
Enservco Corp.
ENSV
| – | – |
-6,373
| Closed | -$153K |
|
Similar funds
SFT
SM
AC
PSI
MSU
BAMS
VFAM
SFP
Clifton Park Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Clifton Park Capital Management held 25 positions worth $1.64B, down 2.5% from $1.69B the previous quarter. Its ten largest holdings account for 87% of the portfolio.
Clifton Park Capital Management withdrew a net $123M in Q1 2015, closing 1 position and reducing 13 holdings. Its most notable exit was Enservco Corp., an estimated $153K position sold in full.
By sector, the portfolio is most concentrated in Industrials at 31% of assets, down from 34% a quarter earlier, followed by Healthcare and Energy.
Against the trend, Clifton Park Capital Management opened a new position in Evofem Biosciences, Inc. Common Stock worth $6.75M.
- Clifton Park Capital Management's largest Q1 2015 buy was Evofem Biosciences, Inc. Common Stock: 9,129 shares worth $6.75M.
- Clifton Park Capital Management added most to Clovis Oncology, Inc. in Q1 2015, an estimated $2.57M increase.
- Clifton Park Capital Management's biggest Q1 2015 reduction was Pediatrix Medical, cutting an estimated $33.7M.
- Clifton Park Capital Management fully exited Enservco Corp. in Q1 2015, selling an estimated $153K.
- Clifton Park Capital Management's ten largest holdings make up 87% of its $1.64B portfolio in Q1 2015.
- Clifton Park Capital Management opened 1 new position and closed 1 in Q1 2015.
- Clifton Park Capital Management's portfolio value fell 2.5% quarter-over-quarter to $1.64B.
Based on Clifton Park Capital Management's 13F filing for Q1 2015, filed 11 May 2015.